LT3173071T - Maropitanto kompozicija - Google Patents

Maropitanto kompozicija

Info

Publication number
LT3173071T
LT3173071T LTEP16200848.6T LT16200848T LT3173071T LT 3173071 T LT3173071 T LT 3173071T LT 16200848 T LT16200848 T LT 16200848T LT 3173071 T LT3173071 T LT 3173071T
Authority
LT
Lithuania
Prior art keywords
maropitanto
composition
maropitanto composition
Prior art date
Application number
LTEP16200848.6T
Other languages
English (en)
Inventor
Marinus Maria Martinus Boeren
Rudolf Johannes Paridaans
Original Assignee
Le Vet B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57460319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3173071(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Le Vet B.V. filed Critical Le Vet B.V.
Publication of LT3173071T publication Critical patent/LT3173071T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP16200848.6T 2015-11-27 2016-11-28 Maropitanto kompozicija LT3173071T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2015865A NL2015865B1 (en) 2015-11-27 2015-11-27 Maropitant Formulation.

Publications (1)

Publication Number Publication Date
LT3173071T true LT3173071T (lt) 2021-07-12

Family

ID=57460319

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16200848.6T LT3173071T (lt) 2015-11-27 2016-11-28 Maropitanto kompozicija

Country Status (13)

Country Link
EP (1) EP3173071B2 (lt)
CY (1) CY1124893T1 (lt)
DK (1) DK3173071T4 (lt)
ES (1) ES2873376T5 (lt)
FI (1) FI3173071T4 (lt)
HR (1) HRP20210986T4 (lt)
HU (1) HUE054584T2 (lt)
LT (1) LT3173071T (lt)
NL (1) NL2015865B1 (lt)
PL (1) PL3173071T5 (lt)
PT (1) PT3173071T (lt)
RS (1) RS62057B2 (lt)
SI (1) SI3173071T1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL312486B2 (en) 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
CN121221782A (zh) 2017-06-30 2025-12-30 傲拓神经科学公司 用于治疗抑郁的nk-1拮抗剂组合物和方法
CN112370451A (zh) * 2020-12-08 2021-02-19 河北科技大学 一种枸橼酸马罗匹坦包合物、注射液及制备方法
WO2022165607A1 (en) * 2021-02-05 2022-08-11 Intelgenx Corp. High loading oral film formulation
AT527172A1 (de) 2023-04-25 2024-11-15 Vetviva Richter Gmbh Maropitantformulierung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6340166A (ja) 1986-08-06 1988-02-20 Fuji Xerox Co Ltd 電子写真感光体
MX18467A (es) 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
LT1713504T (lt) 2004-01-30 2017-09-11 Zoetis Services Llc Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
CN101022822B (zh) 2004-08-24 2012-06-27 第一三共株式会社 生理学活性肽的液体制剂
ES2784629T3 (es) * 2011-11-29 2020-09-29 Jurox Pty Ltd Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona
CN103637987B (zh) 2013-12-09 2015-12-02 韩彬 羟考酮的液体药物组合物

Also Published As

Publication number Publication date
EP3173071B1 (en) 2021-03-24
RS62057B1 (sr) 2021-07-30
EP3173071A1 (en) 2017-05-31
DK3173071T3 (da) 2021-06-28
DK3173071T4 (da) 2026-02-09
HRP20210986T4 (hr) 2026-03-13
SI3173071T1 (sl) 2021-11-30
ES2873376T5 (en) 2026-04-16
PT3173071T (pt) 2021-04-15
CY1124893T1 (el) 2023-01-05
ES2873376T3 (es) 2021-11-03
HUE054584T2 (hu) 2021-09-28
PL3173071T5 (pl) 2026-02-09
NL2015865B1 (en) 2017-06-13
HRP20210986T1 (hr) 2021-09-17
FI3173071T4 (fi) 2026-02-06
PL3173071T3 (pl) 2021-08-16
EP3173071B2 (en) 2025-12-24
RS62057B2 (sr) 2026-03-31

Similar Documents

Publication Publication Date Title
EP3493800A4 (en) CANNABIS
DK3361870T3 (da) Fungicidsammensætninger
DK3416996T3 (da) Hærdelig sammensætning
EP3339331A4 (en) COMPOSITION
EP3398996A4 (en) COMPOSITION
DK3130649T3 (da) Haloolefin-baseret sammensætning
DK3542812T3 (da) Glycopeptidsammensætninger
FR3024363B1 (fr) Composition thermogelifiable
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
DK3528902T3 (da) Ringegelsammensætning
EP3430073A4 (en) COMPOSITION BASED ON A POLYARYLETHERKETONE COMPOSITION
EP3395887C0 (en) FLUOROR RUBBER COMPOSITION
DK3322295T3 (da) Sammensætning
CL2017000639A1 (es) Composición
EP3480228A4 (en) COMPOSITION
DK3331498T3 (da) Nasalsammensætning
DK3316857T3 (da) Multifasiske sammensætninger
EP3556804A4 (en) COMPOSITION
DK3393254T3 (da) Sammensætning
LT3173071T (lt) Maropitanto kompozicija
EP3369418A4 (en) COMPOSITION
EP3236746C0 (en) COMPOSITION
DE102015206660A8 (de) Plattenaufteilanlage
EP3524627A4 (en) COMPOSITION